AJOONINSEAjooni Biotech Limited· Food ProductsHighPositive
Announced Mon, 9 Feb, 2026 · 11:00 IST

Ajooni Biotech bags biggest ever order worth Rs 47.52 crores

Order Above 5pct RevenueBusiness Updates View source PDFExplain this filing

AJOONI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+3.0%Reaction day
₹4.95
prior close
₹5.11
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+2.6%+0.4% vs market
Food Products peers, median of 91sector · industry level+0.8%+2.2% vs sector

On the reaction day the stock moved 0.4 pts more than Nifty Microcap 250 and 2.2 pts more than its Food Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+1.4
10m
+1.6
15m
+1.2
30m
+1.8
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+3.0+2.6+0.4+0.8+2.2
Next day
+4.2+3.6+0.6+1.1+3.2
2d
+3.2+3.1+0.2+1.3+1.9
3d
+3.0+2.6+0.5+0.4+2.6
4d
+0.0+1.1-1.1-0.1+0.1
5d
+1.0+0.3+0.7-1.2+2.2
1w
-0.2+1.6-1.8+0.0-0.2
15d
-19.2-3.9-15.3-5.2-13.9
1m
-10.3-8.1-2.2-8.1-2.2
2m
-12.1-3.1-9.0-6.2-5.9
3m
-13.1+9.2-22.3-0.4-12.8
UpDownMarket · Nifty Microcap 250Sector · Food Products peers, median of 91Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Ajooni Biotech received its largest ever order worth Rs 47.52 crores from an existing customer for cattle feed supply. The order equals about 39 percent of 9M FY26 revenue of Rs 122.87 crores. Company has commissioned a new plant at Khanna Punjab, raising total capacity to 1,80,000 metric tonnes yearly. Board is also discussing a merger with Healthy Biosciences.

Likely market impact

Biggest ever order at about 39 percent of 9M FY26 revenue. New plant and potential merger add further upside. Positive signal for shareholders.